Evidence map›Paper›PMID 41896321›Full record

ArticleScientific reports2026

Isotopically enriched

Max Temnik, Mariia Rudyk, Alexandr Balakin, Sergey Gurin, Taisa Dovbynchuk, Roman Byshovets, Nataliia Dzubenko, Roman Dovhyi, Tetyana Serhiichuk, Ganna Tolstanova and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Max TemnikPhysical Chemistry, Vector Vitale, 3363 NE 163 Street, North Miami Beach, 708D, USA.
Mariia RudykMicrobiology and Immunology Department, Educational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine. rudyk_marie@knu.ua.
Alexandr BalakinPhysical Chemistry, Vector Vitale, 3363 NE 163 Street, North Miami Beach, 708D, USA.
Sergey GurinBiophysics, Metallomix Inc., 175 SW 7 Street, 1702, Miami, FL, 33130, USA.
Taisa DovbynchukMicrobiology and Immunology Department, Educational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Roman ByshovetsDepartment of Internal Diseases, Bogomolets National Medical University, 13, Shevchenko Blvd., Kyiv, 01004, Ukraine.
Nataliia DzubenkoEducational and Scientific Institute of High Technologies, Taras Shevchenko National University of Kyiv, 4g, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Roman DovhyiMicrobiology and Immunology Department, Educational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Tetyana SerhiichukMicrobiology and Immunology Department, Educational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Ganna TolstanovaEducational and Scientific Institute of High Technologies, Taras Shevchenko National University of Kyiv, 4g, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Larysa SkivkaMicrobiology and Immunology Department, Educational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine.

Funding

Taras Shevchenko National University of Kyiv N 18DP036-10
6 · The paper itself

Abstract

A growing body of research indicates that systemic inflammation contributes substantially to the progression of Parkinson's disease (PD). Foundational studies propose that targeting inflammatory pathways may offer therapeutic benefits for PD and other neurodegenerative conditions. Our previous work demonstrated that a novel zinc aspartate compound enriched with the light isotope

Indexed as

Aspartic AcidDysbiosisGastrointestinal MicrobiomeInflammationParkinson DiseaseZincAnimalsDisease Models, AnimalLipopolysaccharidesMaleRatsAspartic AcidLipopolysaccharidesZincAnxiety-like behaviorGut dysbiosisInflammationMotor functionParkinson’s diseaseStable light isotope-enriched zinc aspartate

Identifiers

PMID41896321
PMCPMC13039921

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.